Review

You have free access to this content

Assessment of subclinical atherosclerosis and cardiovascular risk

  1. R. Michael BENITEZ M.D.*,
  2. Robert A. Vogel M.D.

Article first published online: 3 FEB 2009

DOI: 10.1002/clc.4960241003

Issue

Clinical Cardiology

Clinical Cardiology

Volume 24, Issue 10, pages 642–650, October 2001

Additional Information

How to Cite

Michael BENITEZ, R. and Vogel, R. A. (2001), Assessment of subclinical atherosclerosis and cardiovascular risk. Clin Cardiol, 24: 642–650. doi: 10.1002/clc.4960241003

Author Information

  1. Division of Cardiology, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA

*R. Michael Benitez, M.D. Room S3B06 University of Maryland Hospital 22 S. Greene St. Baltimore, MD 21201, USA e-mail: MBenitez@medicine.umaryland.edu

Publication History

  1. Issue published online: 3 FEB 2009
  2. Article first published online: 3 FEB 2009
  3. Manuscript Accepted: 13 SEP 2000
  4. Manuscript Received: 18 JUL 2000

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (990K)

References

  • 1
    Braunwald E: Shattuck Lecture—Cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities. N Engl J Med 1997; 337: 1360–1369
  • 2
    Pearson A, Laurora I, Chu H, Kafonek: The lipid treatment assessment project (L-TAP). Arch Intern Med 2000; 160: 459–467
  • 3
    Schrott HG, Bittner V, Vittinghoff E, Herrington DM, Hulley S: Adherence to national cholesterol education program treatment goals in postmenopausal women with heart disease. The heart and estrogen/progestin replacement study (HERS). The HERS research group. J Am Med Assoc 1997; 277: 1281–1286
  • 4
    Oliver MF, Samuel E, Morley P, Young GP, Kapur PL: Detection of coronary artery calcification during life. Lancet 1964; 1: 891–895
  • 5
    Margolis JR, Chen J, Kong Y: The diagnostic and prognostic significance of coronary artery calcification: A report of 800 cases. Radiology 1980; 137: 609–616
  • 6
    Shemesh J, Tenenbaum A, Fisman E, Apter S, Rath S, Rozeenman J, Itzchak Y, Motro M: Absence of coronary calcification on double-helical CT scans: Predictor of angiographically normal coronary arteries in elderly women? Radiology 1996; 199: 665–668
  • 7
    Shemesh J, Fisman E, Tenenbaum A, Apter S, Leibovitch L, Rath S, Itzchak Y, Motro M: Coronary artery calcification in women with syndrome X: Usefulness of double-helical CT for detection. Radiology 1997; 205: 697–700
  • 8
    Baskin KM, Stanford W, Thompson BH, Hoffman E, Tajik J, Heery SD: Comparison of electron beam and helical computed tomography in assessment of coronary artery calcification (abstr). Circulation 1995; 92 (suppl I): I–651
  • 9
    Budhoff MJ, Georgiou D, Brody A, Agatston AS, Kennedy J, Wolfkiel C, Stanford W, Shields P, Lewis RJ, Janowitz WR, Rich S, Brundage BH: Ultrafast computed tomography as a diagnostic modality in the detection of CAD: A multicenter study. Circulation 1996; 93: 898–904
  • 10
    Borman JL, Stanford W, Stenberg RG, Winniford MD, Berbaum KS. Talman CL, Galvin JR: Ultrafast tomographic detection of coronary artery calcification as an indicator of stenosis. Am J Card Imaging 1992; 6: 191–196
  • 11
    Chou T, Redberg R, Eitetsu K, Durairaj A, Messenger JC, Sudhir K, Kane JP, Malloy MJ: Screening for coronary artery atherosclerosis by detection of calcium on electron beam computed tomography: Correlation with intravascular ultrasound in asymptomatic patients with primary hyperlipidemia (abstr). Circulation 1996; 94 (supplI): I–360
  • 12
    Devries S, Wolfkiel C, Fusman B, Bakdash H, Ahmed A, Levy P, Chomka E, Kondos G, Zajac E, Rich S: Influence of age and gender on the presence of coronary calcium detected by ultrafast computed tomography. J Am Med Assoc 1995; 25: 76–82
  • 13
    Guerci AD, Spadaro LA, Goodman K, Lledo-Perez A, Newstein D, Lerner G, Arad Y: Comparison of electron beam computed tomography scanning and conventional risk factor assessment for the prediction of angiographic coronary artery disease. J Am Coll Cardiol 1998; 32: 673–679
  • 14
    Schmermund A, Denktas AE, Rumberger JA, Christian TF, Sheedy PF, Bailey KR, Schwartz RS: Independent and incremental value of coronary artery calcium for predicting the extent of angiographic coronary artery disease. J Am Coll Cardiol 1999; 34: 777–786
  • 15
    Kennedy J, Shavelle R, Wang S, Budoff M, Detrano RC: Coronary calcium and standard risk factors in symptomatic patients referred for coronary angiography. Am Heart J 1998; 135: 696–702
  • 16
    Detrano R, Hsiai T, Wang S, Puentes G, Fallavollita J, Shields R Stanford W, Wolfkiel C, Georgiou D, Budoff M, Reed J: Prognostic value of coronary calcification and angiographic stenoses in patients undergoing coronary angiography. J Am Coll Cardiol 1996; 27: 285–290
  • 17
    Detrano RC, Wong ND, Doherty TM, Shavelle RM, Tang W, Ginzton LE, Budoff MJ, Narahara KA: Coronary calcium does not accurately predict near-term future coronary events in high-risk adults. Circulation 1999; 99: 2633–2638
  • 18
    Arad Y, Spadaro LA, Goodman K, Lledo-Perez A, Sherman S, Lerner G, Guerci AD: Predictive value of electron beam computed tomography of the coronary arteries—19 month follow up of 1,173 asymptomatic subjects. Circulation 1996; 93: 1951–1953
  • 19
    Grover SA, Coupal L, Hu X: Identifying adults at increased risk of coronary disease. J Am Med Assoc 1995; 274: 801–806
  • 20
    Secci A, Wong N, Tang W, Wang S, Doherty T, Detrano R: Electron beam computed tomographic coronary calcium as a predictor of coronary events. Comparison of two protocols. Circulation 1997; 96: 1122–1129
  • 21
    Callister TQ, Cooil B, Raya SP, Lippolis NJ, Russo DJ, Raggi P: Coronary artery disease: Improved reproducibility of calcium scoring with an electron beam CT volumetric method. Radiology 1998; 208: 807–814
  • 22
    O'Rourke RA, Brundage BH, Froehlicher VF, Greenland P, Grundy SM, Hachamovitch R, Pohost GM, Shaw LJ, Weintraub WS, Winters WL, Forrester JS, Douglas PS, Faxon DP, Fisher JD, Gregoratos G, Hochman JS, Hutter AM, Kaul S, Wolk MJ: American College of Cardiology/American Heart Association expert consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. Circulation 2000; 102: 126–140
  • 23
    Van Geuns RJ, de Bruin HG, Rensing BJ, van Ooijen PM, Oudkerk M, de Feyter PJ: Magnetic resonance imaging of the coronary arteries: Clinical results from three dimensional evaluation of a respiratory gated technique. Heart 1999; 82 (4):515–519
  • 24
    Regenfus M, Ropers D, Achenbach S, Kessler W, Laub G, Daniel W, Moshage W: Noninvasive detection of coronary artery stenosis using contrast-enhanced three-dimensional breath-hold magnetic resonance coronary angiography. J Am Coll Cardiol 2000; 36: 44–50
  • 25
    Kessler W, Laub G, Achenbach S, Ropers D, Moshage W, Daniel WG: Coronary arteries: MR angiography with fast contrast enhanced three dimensional breath hold imaging—initial experience. Radiology 1999; 210 (2): 566–572
  • 26
    Taylor AM, Keegan J, Jhooti P, Gatehouse PD, Firmin DN, Pennell DJ: Differences between normal subjects and patients with coronary artery disease for three different MR coronary angiography respiratory suppression techniques. J Magnet Reson Imag 1999; 9 (6): 786–793
    Direct Link:
  • 27
    Sakuma H, Takeda K, Higgins CB: Fast magnetic resonance imaging of the heart. Eur J Radiol 1999; 29: 101–113
  • 28
    Duerinckx AJ: Coronary MR angiography. Radiol Clin North Am 1999; 37: 273–318
  • 29
    Hundley WG, Hamilton CA, Clarke GD, Hillis LD, Herrington DM, Lange RA, Applegate RJ, Thomas MS, Payne J, Link KM, Peshock RM: Visualization of functional assessment of proximal and middle left anterior descending coronary stenoses in humans with magnetic resonance imaging. Circulation 1999; 99 (25): 3248–3254
  • 30
    Simon A, Giral P, Levenson J: Extracoronary atherosclerotic plaque at multiple sites and total coronary calcification deposit in asymptomatic men. Circulation 1995; 92: 1414–1421
  • 31
    Mitchell JR, Schwartz CJ: Relationship between arterial disease at different sites. Br Med J 1962; 1: 1293–1301
  • 32
    Geroulakos G, O'Gorman D, Kalodiki E, Sheridan DJ, Nicolaides AN: The carotid intima-media thickness as a marker of the presence of severe symptomatic coronary artery disease. Eur Heart J 1994; 15: 781–785
  • 33
    Crouse JR, Craven TE, Hagaman AP, Bond MG: Association of coronary disease with segment specific intimal-medial thickening of the extracranial carotid artery. Circulation 1995; 92: 1141–1147
  • 34
    Blankenhorn DH, Selzer RH, Crawford DW, Barth JD, Liu CH, Mack WJ, Alaupovic P: Beneficial effects of colestipol-niacin therapy on the common carotid. Circulation 1993; 88: 20–28
  • 35
    Crouse JR, Byington RP, Bond MG, Espeland MA, Craven TE, Sprinkle JW, McGovern ME, Furberg CD: Pravastatin, lipids and atherosclerosis in the carotid arteries (PLAC-II). Am J Cardiol 1995; 75: 445–459
  • 36
    Furberg CD, Adams HP, Appelgate WB, Byington RP, Espeland MA, Hartwell T, Hunninghake DB, Lefkowitz DS, Probstfield J, Riley WA: Effect of lovastatin on early carotid atherosclerosis and clinical events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Circulation 1994; 90: 1679–1687
  • 37
    Salonen R, Nyyssonen K, Porkkala E, Rmmukainen J, Belder R, Park JS, Salonen JT: Kuopio Atherosclerosis Prevention Study (KAPS)—a population based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation 1995; 92: 1758–1764
  • 38
    Gostomyzyk JG, Heller WD, Gerhardt P, Lee PN, Keil U: B-scan ultrasound examination of the carotid arteries within a representative population (MONICA project Augsburg). Klin Wochenschr 1988; 66 (suppl II): 58–65
  • 39
    Craven TE, Ryu JE, Espeland MA, Kahl FR, McKinney WM, Toole JF, McMahan MR, Thompson CJ, Heiss G, Crouse JR: Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis: A case control study. Circulation 1990; 82: 1230–1242
  • 40
    Geroulakos G, O'Gorman D, Nicolaides A, Sheridan D, Elkeles R, Shaper AG: Carotid intimal-medial thickness: Correlation with the British Regional heart study risk score. J Intern Med 1994; 235: 431–433
    Direct Link:
  • 41
    Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, Clegg LX: Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The atherosclerosis risk in communities (ARIC) study, 1987–1993. Am J Epidemiol 1997; 146: 483–494
  • 42
    Salonen JT, Salonen R: Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 1991: 11 (5): 1245–1249
  • 43
    Simons P, Algra A, Bots ML. Banga JD, Grobbee DE, van der Graaf Y: Common carotid intima-media thickness and arterial stiffness—indicators of cardiovascular risk in high-risk patients. The SMART study (Second Manifestations of ARTerial disease). Circulation 1999; 100: 951–957
  • 44
    Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu CH, Azen SP: The role of carotid arterial intima-medial thickness in predicting clinical coronary events. Ann Intern Med 1998; 128: 262–269
  • 45
    Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P: Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986; 315: 1046–1051
  • 46
    Zeiher AM, Drexler H, Wollschlager H, Just H: Modulation of coronary vasomotor tone in humans: Progressive endothelial dysfunction with different stages of coronary atherosclerosis. Circulation 1991; 83: 391–401
  • 47
    Yasue H, Matsuyama K, Okumura K, Morikami Y, Ogawa H: Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment: Possible role of early coronary atherosclerosis. Circulation 1990; 81: 482–490
  • 48
    Anderson TJ, Uehata A, Gerhard MD, Mederdith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC: Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995; 26: 1235–1241
  • 49
    Takase B, Uehata A, Akima T, Nagai T, Nishioka T, Hamabe A, Satomura K, Ohsuzu F, Kurita A: Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease. Am J Cardiol 1998; 82: 1535–1539, A7–8
  • 50
    Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111–1115
  • 51
    Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfiled JE: Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994; 24: 1468–1474
  • 52
    Jensen-Urstad K, Johansson J, Jensen-Urstad M: Vascular function correlates with risk factors for cardiovascular disease in a healthy population of 35–year-old subjects. J Intern Med 1997; 241: 507–513
    Direct Link:
  • 53
    Clarkson P, Celermajer DS, Powe AJ, Donald AE, Henry RM, Deanfield JE: Endothelium-dependent dilatation is impaired in young healthy subjects with a family history of premature coronary disease. Circulation 1997; 96: 3378–3383
  • 54
    Correti MC, Plotnick GD, Vogel RA: Smoking correlates with flow-mediated brachial artery vasoactivity but not cold pressor vasoactivity in men with coronary artery disease. Int J Card Imaging 1998; 14: 11–17
  • 55
    Yataco AR, Corretti MC, Gardner AW, Womack CJ, Katzel LI: Endothelial reactivity and cardiac risk factors in older patients with peripheral arterial disease. Am J Cardiol 1999; 83: 754–758
  • 56
    Clarkson P, Montgomery HE, Mullen MJ, Donald AE, Powe AJ, Bull T, Jubb M, World M, Deanfield JE: Exercise training enhances endothelial function in young men. J Am Coll Cardiol 1999; 33: 1379–1385
  • 57
    Plotnick GD, Corretti MC, Vogel RA: Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal. J Am Med Assoc 1997; 278: 1682–1686
  • 58
    Lundman P, Eriksson M, Schenck-Gustafsson K, Karpe F, Tornvall P: Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease. Circulation 1997; 96: 3266–3268
  • 59
    Jodoin I, Bussieres LM, Tardif JC, Juneau M: Effect of a short-term primary prevention program on endothelium-dependent vasodilation in adults at risk for atherosclerosis. Can J Cardiol 1999; 15: 83–88
  • 60
    Vogel RA, Corretti MC, Plotnick GD: Changes in flow-mediated brachial artery vasoreactivity with lowering of desirable cholesterol levels in healthy middle-aged men. Am J Cardiol 1996; 77: 37–40
  • 61
    Dupuis J, Tardif JC, Cernacek P, Théroux P: Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial. Circulation 1999; 99: 3227–3233
  • 62
    Corretti MC, Plotnick GD, Vogel RA: Correlation of cold pressor and flow-mediated brachial artery diameter responses with the presence of coronary artery disease. Am J Cardiol 1995; 75: 783–787
  • 63
    Neunteufl T, Katzenschlager R, Hassan A, Klaar U, Schwarzacher S, Glogar D, Bauer P, Weidinger F: Systemic endothelial dysfunction is related to the extent and severity of coronary of coronary artery disease. Atherosclerosis 1997; 129: 111–118
  • 64
    Kaku B, Mizuno S, Ohsato K, Murakami T, Moriuchi I, Arai Y, Nio Y, Hirase H, Nagata M, Takahashi Y, Ohnaka M: The correlation between stenosis index and flow-mediated dilation of the brachial Jpn Circ J 1998; 62: 425–430
  • 65
    Enderle MD, Schroeder S, Ossen R, Meisner C, Baumbach A, Haering HU, Karsch KR, Pfohl M: Comparison of peripheral endothelial dysfunction and intimal media thickness in patients with suspected coronary artery disease. Heart 1998; 80: 349–354
  • 66
    Lieberman EH, Gerhard MD, Uehata A, Selwyn AP, Ganz P, Yeung AC, Creager MA: Flow-induced vasodilation of the human brachial artery is impaired in patients < 40 years of age with coronary artery disease. Am J Cardiol 1996; 78: 1210–1214
  • 67
    Maseri A: Inflammation, atherosclerosis, and ischemic events—exploring the hidden side of the moon. N Engl J Med 1997; 336: 1014–1016
  • 68
    Shor A, Kuo CC, Patton DL: Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J 1992; 82: 158–161
  • 69
    Coombes BK, Mahoney JB: Chlamydia pneumoniae infection of human endothelial cells induces proliferation of smooth muscle cells via an endothelial cell-derived soluble factor(s). Infect Immun 1999; 67: 2909–2915
  • 70
    Krull M, Klucken A, Wupperman F, Fuhrmann O, Margerl C, Seybold J, Hippenstiel S, Hegemann JH, Jantos CA, Suttorp N: Signal transduction pathways activated in endothelial cells following infection with Chlamydia pneumoniae. J Immunol 1999; 162: 4834–4841
  • 71
    Kalayoglu MV, Hoerneman B, La Verda D, Morrison SG, Morrison RP, Byrne GI: Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae. J Infect Dis 1999; 180: 780–790
  • 72
    Kalayoglu MV, Byrne GI: A Chlamydia pneumoniae component that induces macrophage foam cell formation is a chlamydial lipopolysaccharide. Infect Immun 1998; 66: 5067–5072
  • 73
    Kol A, Sukhova GK, Lichtman AH, Libby P: Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor alpha and matrix metalloproteinase expression. Circulation 1998; 98: 300–307
  • 74
    Kol A, Bourcier T, Lichtman AH, Libby P: Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J Clin Invest 1999; 103: 571–577
  • 75
    Dechend R, Maass M, Gieffers J, Dietz R, Scheidereit C, Leutz A, Gulba DC: Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-Kappa B and induces tissue factor and PAI-1 expression: A potential link to arteriosclerosis. Circulation 1999; 100: 1369–1373
  • 76
    Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ: Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 1997; 96: 404–407
  • 77
    Anderson JL, Muhlestein JB, Carlquist J, Allen A, Trehan S, Nielson C, Hall S, Brady J, Egger M, Home B, Lim T: Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection. The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infarction with Chlamydia (ACADEMIC) Study. Circulation 1999; 99: 1540–1547
  • 78
    Gurfinkel E, Bozovich G, Beck E, Testa E, Livellara B, Mautner B: Treatment with the antibiotic roxithromycin in patients with acute non-Q wave coronary syndromes. The final report of the ROXIS study. Eur Heart J 1999; 20: 121–127
  • 79
    Van der Wal AC, Becker AE, van der Loos CM, Das PK: Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994; 89: 36–44
  • 80
    Kloner RA, Giacomelli F, Alker KJ, Hale SL, Matthews R, Bellows S: Influx of neutrophils into the walls of large epicardial coronary arteries in response to ischemia/reperfusion. Circulation 1991; 84: 1758–1772
  • 81
    Friedman GD, Klatsky AL, Siegelaub AB: The leukocyte count as a predictor of myocardial infarction. N Engl J Med 1974; 290: 1275–1278
  • 82
    Zalokar JB, Richard JL, Claude JR: Leukocyte count, smoking and myocardial infarction. N Engl J Med 1981; 304: 402–408
  • 83
    Grimm RH, Neaton JD, Ludwig H: Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. J Am Med Assoc 1985; 254: 1932–1937
  • 84
    Prentice RL, Szatrowski TP, Fujikuru T, Kato H, Mason MW, Hamilton HH: Leukocyte counts and coronary heart disease in a Japanese cohort. Am J Epidemiol 1982; 116: 496–506
  • 85
    Kannel WB, Anderson K, Wilson PW: White blood cell count and cardiovascular disease—insights from the Framingham Study. J Am Med Assoc 1992; 267: 1253–1256
  • 86
    Manttari M, Manninen V, Koskinen P, Huttunen JK, Oksanen E, Tenkanen L, Heinonen OP, Frick MH: Leukocytes as a coronary risk factor in a dyslipidemic male population. Am Heart J 1992; 123: 873–877
  • 87
    Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973–979
  • 88
    Ridker PM, Glynn RJ, Hennekens CH: C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998; 97: 2007–2011
  • 89
    Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E: Long-term effects of pravastatin on plasma concentration of c-reactive protein. The Cholesterol and Recurrent Events (CARE) investigators. Circulation 1999; 100: 230–235
  • 90
    Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, Hutchinson WL, Pepys MB: C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA Augsburg cohort study, 1984–1992. Circulation 1999; 99: 237–242
  • 91
    Ridker PM, Buring JE, Shih J, Mafias M, Hennekens CH: Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998; 98: 731–733
  • 92
    Grundy SM, Pasternak R, Greenland P, Smith S, Fuster V: Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 1999; 34: 1348–1359
  • 93
    Ernst E, Koenig W: Fibrinogen and cardiovascular risk. Vase Med 1997; 2: 115–125
  • 94
    Danesh J, Muir J, Wong YK, Ward M, Gallimore JR, Pepys MB: Risk factors for coronary heart disease and acute phase proteins. A population based study. Eur Heart J 1999; 20: 954–959
  • 95
    Lindberg G, Rastam L, Nilsson-Ehle P, Lundblad A, Ranstam J, Folsom AR, Burke GL: Serum sialic acid and sialoglycoproteins in asymptomatic carotid artery atherosclerosis. ARIC investigators. Atherosclerosis Risk in Communities. Atherosclerosis 1999; 146: 65–69
  • 96
    De Maat MP, Kastelein JJ, Jukema JW, Zwinderman AH, Jansen H, Groenemeier B, Bruschke AV, Kluft C: 455G/A polymorphism of the beta-fibrinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men: Proposed role for an acute phase reaction pattern of fibrinogen. REGRESS group. Arterioscler Thromb Vasc Biol 1998; 2: 265–271
  • 97
    Wu KK, Aleksic N: Platelet glycoprotein polymorphism and risk for coronary heart disease. Blood Coagul Fibrinol 1999: 10 (suppl 1): S63–S65
  • 98
    De Maat MP, Bladbjerg EM, Johansen LG, de Knijff P, Gram J, Kluft C, Jesperen J: DNA polymorphisms and plasma levels of vascular disease risk factors in Greenland Inuit: Is there a relation with the low risk of cardiovascular disease in Inuit? Thromb Haemost 1999; 81: 547–552
  • 99
    Junker R, Heinrich J, Schulte H, van de Loo J, Assmann G: Coagulation factor VII and the risk of coronary heart disease in healthy men. Arterioscler Thromb Vasc Biol 1997; 17: 1539–1544
  • 100
    De Maat MP, Green F, de Knijff P, Jespersen J, Kluft C: Factor VII polymorphisms in populations with different risks of cardiovascular disease. Arterioscler Thromb Vasc Biol 1997; 17: 1918–1923
  • 101
    Ghaddar HM, Folsom AR, Aleksic N, Heame LB, Chambless LE, Morrissey JH, Wu KK: Correlation of factor Vila values with factor VII gene polymorphism, fasting and postprandial triglyceride levels, and subclinical atherosclerosis. Circulation 1998; 98: 2815–2821
  • 102
    Folsom AR, Rosamond WD, Shahar E, Coooper LS, Aleksic N, Nieto FJ, Rasmussen ML, Wu KK: Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) study investigators. Circulation 1999; 100: 736–742
  • 103
    Wu KK: Hemostatic tests in the prediction of atherothrombotic disease. Int J Clin Lab Res 1997; 27: 145–152
  • 104
    Koenig W, Sund M, Filipiak B, Doring A, Lowel H, Ernst E: Plasma viscosity and the risk of coronary heart disease: Results from the MONICA Augsburg cohort study, 1984–1992. Arterioscler Thmmb Vase Biol 1998; 18: 768–772
  • 105
    Saloma V, Matei C, Aleksic N, Sansores-Garcia L, Folsom AR, Juneja H, Chabless LE, Wu KK: Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: A case-cohort study. Lancet 1999; 353: 1729–1734
  • 106
    McCully KS: Vascular pathology of homocysteinemia. Am J Pathol 1969: 56: 111–128
  • 107
    Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, Andria G, Boers GH, Bromberg IL, Cerone R: Natural history of homocysteinuria due to cystathione beta synthase deficiency. Am J Hum Genet 1985; 37: 1–25
  • 108
    Rolland PH, Friggi A, Barlaiter A, Piquet P, Latrille V, Faye MM, Guillou J, Charpiot P, Bodard H, Ghiringhelli O: Hyperhomo-cysteinemia induced vascular damage in the minipig. Captopril-hydrochlorothiazide combination prevents elastic alterations. Circulation 1995; 91: 1161–1174
  • 109
    Lentz SR, Sobey CG, Piegors DJ, Bhopatkar MY, Faraci FM, Malinow MR, Hiestad DD: Vascular dysfunction in monkeys with diet-induced hyperhomocysteinemia. J Clin Invest 1996; 98: 328–329
  • 110
    Chambers JC, McGregor A, Jean-Marie J, Kooner JS: Acute hyperhomocysteinemia and endothelial dysfunction. Lancet 1998; 351: 36–37
  • 111
    Malinow MR, Bostom AG, Krauss RM: Homocysteine, diet, and cardiovascular diseases: A statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1999; 99: 178–182
  • 112
    Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97 (18):1837–1847
Get PDF (990K)